Insecticides India Ltd

Insecticides India Ltd

₹ 866 2.00%
11 Jun - close price
About

Insecticides India is into manufacturing of agrochemicals (technicals and formulations) and biological and household products. They cater to Indian market where they directly sell to the end consumer and also sell technicals and formulations to the companies who are in the business of formulation. They also export to 30 countries with more than 100 customers through registrations. IIL has more than 75 registrations so far.[1]

Key Points

Product Offerings
The company is one of India’s leading crop protection and Nutrition companies, with a portfolio of 20+ technical products and 125 formulation products, including Insecticides, Herbicides, Fungicides, and Biological and PGR products, under brands like Tractor, Green Label, Pulsor, Hakama, and others. Its premium portfolio includes 11 Focused Maharatna products and 33 Maharatna under brands like Hercules, Lethal, Hachiman, Shinwa, etc. [1] [2] [3] [4]

  • Market Cap 2,557 Cr.
  • Current Price 866
  • High / Low 1,085 / 532
  • Stock P/E 18.0
  • Book Value 366
  • Dividend Yield 0.35 %
  • ROCE 17.4 %
  • ROE 13.5 %
  • Face Value 10.0

Pros

Cons

  • The company has delivered a poor sales growth of 7.97% over past five years.
  • Company has a low return on equity of 10.5% over last 3 years.
  • Dividend payout has been low at 7.57% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
278 561 582 357 302 640 696 358 272 657 627 358 359
244 502 514 333 331 594 614 332 264 585 538 327 330
Operating Profit 34 58 68 23 -29 46 82 26 9 72 90 31 28
OPM % 12% 10% 12% 7% -9% 7% 12% 7% 3% 11% 14% 9% 8%
2 1 0 0 0 4 0 1 5 3 2 0 3
Interest 1 1 3 5 4 3 3 3 2 2 2 1 2
Depreciation 7 7 6 6 7 7 7 7 8 7 7 8 7
Profit before tax 28 51 60 12 -39 40 72 17 4 65 82 22 22
Tax % 20% 25% 25% 25% -25% 26% 26% 28% -106% 25% 25% 22% 37%
22 38 45 9 -29 29 53 12 8 49 61 17 14
EPS in Rs 7.54 12.94 15.15 3.17 -9.90 9.85 17.96 4.16 2.62 16.56 20.78 5.87 4.69
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
240 893 906 994 1,073 1,194 1,363 1,420 1,504 1,801 1,966 2,000
211 782 814 882 925 1,006 1,207 1,268 1,333 1,679 1,804 1,779
Operating Profit 28 111 92 112 148 188 156 153 171 122 163 221
OPM % 12% 12% 10% 11% 14% 16% 11% 11% 11% 7% 8% 11%
1 0 0 7 3 1 3 -2 3 1 10 8
Interest 4 33 26 20 16 15 24 7 7 13 11 7
Depreciation 1 15 16 16 17 20 24 25 26 26 29 29
Profit before tax 24 64 50 82 118 153 111 120 141 84 132 193
Tax % 14% 14% 21% 27% 29% 20% 22% 21% 24% 25% 23% 26%
21 55 40 60 84 123 87 94 107 63 102 142
EPS in Rs 7.34 19.24 12.77 19.26 27.19 39.62 28.04 30.29 36.29 21.36 34.59 47.98
Dividend Payout % 12% 0% 10% 7% 5% 3% 10% 4% 6% 14% 9% 0%
Compounded Sales Growth
10 Years: 8%
5 Years: 8%
3 Years: 10%
TTM: 2%
Compounded Profit Growth
10 Years: 10%
5 Years: 10%
3 Years: 9%
TTM: 41%
Stock Price CAGR
10 Years: 10%
5 Years: 26%
3 Years: 17%
1 Year: 42%
Return on Equity
10 Years: 13%
5 Years: 11%
3 Years: 11%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 13 13 21 21 21 21 21 21 20 30 30 29
Reserves 88 278 388 444 527 641 711 800 850 889 984 1,056
14 322 206 237 114 305 191 100 54 163 87 105
87 308 321 277 338 388 372 505 473 615 613 709
Total Liabilities 201 920 936 978 1,000 1,356 1,294 1,426 1,396 1,696 1,714 1,898
25 210 198 185 232 240 239 239 253 263 284 287
CWIP 1 38 51 58 17 19 39 59 91 123 142 156
Investments 17 3 3 11 17 12 12 14 16 17 20 29
159 670 684 725 735 1,084 1,004 1,115 1,037 1,294 1,268 1,426
Total Assets 201 920 936 978 1,000 1,356 1,294 1,426 1,396 1,696 1,714 1,898

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
6 -6 86 4 182 -133 242 155 135 -11 184 93
-4 -34 -19 -14 -26 -49 -24 -113 9 -86 -43 -38
-3 36 -64 9 -143 172 -159 -104 -115 80 -98 -61
Net Cash Flow -1 -4 4 -0 13 -11 59 -61 30 -17 43 -5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 50 68 84 78 80 75 86 65 70 60 55 70
Inventory Days 230 220 190 232 214 355 202 248 228 247 220 238
Days Payable 106 118 114 108 128 141 96 136 117 128 114 136
Cash Conversion Cycle 174 170 159 201 166 289 192 177 181 178 161 172
Working Capital Days 102 138 137 155 126 206 147 132 123 124 109 122
ROCE % 27% 12% 16% 20% 21% 14% 15% 16% 10% 13% 17%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
72.16% 72.16% 72.16% 72.16% 72.16% 72.16% 72.16% 72.16% 72.16% 72.16% 72.30% 72.30%
6.66% 6.32% 6.27% 6.46% 6.02% 5.19% 4.41% 4.31% 4.36% 5.43% 5.13% 4.50%
10.98% 10.94% 10.94% 10.77% 10.53% 9.36% 9.12% 9.14% 9.08% 9.06% 9.24% 9.59%
10.20% 10.58% 10.64% 10.62% 11.30% 13.31% 14.32% 14.40% 14.41% 13.36% 13.34% 13.63%
No. of Shareholders 14,23320,22319,18916,35518,01218,86818,23219,25219,47422,48422,84922,688

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls